Shortcuts
Please wait while page loads.
Visit Libero WebOPAC . Default .
PageMenu- Main Menu-
Page content

Catalogue Display

Bad blood : secrets and lies in a Silicon Valley startup / John Carreyrou.

Bad blood : secrets and lies in a Silicon Valley startup / John Carreyrou.

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When John Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.

Item Information
Barcode Shelf Location Collection Volume Ref. Branch Status Due Date Reserve
200375208 338.7681 CAR
Adult Non Fiction   Batemans Bay . . Available .  
. Catalogue Record 823460 ItemInfo Beginning of record . Catalogue Record 823460 ItemInfo Top of page .
Catalogue Information
Field name Details
Shelf Location 338.7681 CAR
Author Carreyrou, John
Title Bad blood : secrets and lies in a Silicon Valley startup / John Carreyrou.
Publication Details London : Picador, 2019.
©2018
Description xii, 339 pages ; 20 cm.
Notes Originally published: 2018.
A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When John Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.
Subject Holmes, Elizabeth
Theranos (Firm)
Hematologic equipment industry -- United States
Fraud -- United States
Links to Related Works
Subject References:
Authors:
Classification:
.
Enriched Content Catalogue Record 823460
. . .
Catalogue Information 823460 Beginning of record . Catalogue Information 823460 Top of page .